Marvell Technology Soars After Report SoftBank Explored Takeover, Eyeing ARM Tie‑Up

6 November 2025

Marvell Technology (NASDAQ: MRVL) jumped on Thursday after Bloomberg reported that SoftBank Group explored a takeover of the U.S. chipmaker earlier this year—an approach that, if completed, would have marked the largest deal in semiconductor history. While no agreement was reached and talks aren’t active, people familiar with the matter said interest could be revived. ^[1]

SoftBank explored a Marvell takeover earlier in 2025, studying the company “on and off for years,” according to Bloomberg reporting. The two sides failed to agree on terms. ^[2]
The strategic idea under discussion included combining Marvell with ARM, the U.K. chip designer SoftBank controls—tying Marvell’s data‑center and networking silicon to ARM’s CPU ecosystem amid the AI boom. ^[3]
Scale: Such a transaction would have been the semiconductor industry’s largest‑ever deal, highlighting the intense race to build end‑to‑end AI platforms. ^[4]
Current status: No active negotiations now, though interest could resurface, sources told Bloomberg. ^[5]

Why SoftBank might want Marvell

SoftBank founder Masayoshi Son has been vocal about betting big on AI hardware. Marvell’s expertise in custom accelerators, high‑speed networking, and cloud/datacenter silicon could complement ARM’s CPU IP—potentially creating a portfolio spanning compute and connectivity for hyperscalers building AI infrastructure. That logic aligns with the Bloomberg account that Son has studied Marvell repeatedly as a beneficiary of the AI build‑out. ^[6]

How the market reacted

Premarket: MRVL spiked nearly 10% to about $102 after the Bloomberg report circulated, before paring gains. ^[7]
Intraday (12:48 UTC): Shares were still up about 6% near $92.90 (chart above).
Coverage from Seeking Alpha echoed the move and the source report, noting the takeover exploration and the lack of current talks. ^[8]

What would stand in the way of a deal

Regulatory scrutiny would be intense. Any cross‑border acquisition of a major U.S. chip supplier would likely face CFIUS review and antitrust questions in multiple jurisdictions. The sheer size—signaled by Bloomberg and partner outlets as record‑setting for semis—would add further complexity to financing and approvals. (Context on “largest‑ever” characterization: Bloomberg’s reporting via The Japan Times.) ^[9]

Timeline

2:38 a.m. UTC (Nov. 6): Bloomberg publishes its first report that SoftBank explored a Marvell takeover.
9:10 a.m. UTC (Nov. 6): Bloomberg updates the story. ^[10]

What to watch next

Any renewed outreach by SoftBank or fresh board‑level signals from Marvell. (The reporting says interest could be revived, even though talks are not active now.) ^[11]
Follow‑on market moves in related names—particularly ARM—as investors handicap the likelihood of a combination and the broader AI‑chip consolidation theme. MarketWatch’s early read-through already tied the report to enthusiasm around ARM and AI infrastructure. ^[12]
Official statements: Neither side has confirmed the exploratory talks in today’s coverage; watch company communications and regulatory filings for any change in posture. ^[13]

Sources (Nov. 6, 2025)

Bloomberg: initial and updated report on SoftBank’s explored takeover of Marvell. ^[14]
The Japan Times (publishing Bloomberg’s account): details on ARM‑combination idea, largest‑ever framing, and status of talks. ^[15]
MarketWatch: market reaction and M&A trigger framing. ^[16]
Seeking Alpha: market recap noting SoftBank’s exploration and lack of current negotiations. ^[17]
Reuters/Refinitiv via TradingView: premarket price context near $102. ^[18]

SoftBank explored takeover of Marvell in $100B AI chip bid - Byte News Daily

Watch this video on YouTube.

References

1. www.bloomberg.com, 2. www.bloomberg.com, 3. www.japantimes.co.jp, 4. www.japantimes.co.jp, 5. www.japantimes.co.jp, 6. www.bloomberg.com, 7. www.tradingview.com, 8. seekingalpha.com, 9. www.japantimes.co.jp, 10. www.bloomberg.com, 11. www.japantimes.co.jp, 12. www.marketwatch.com, 13. www.marketwatch.com, 14. www.bloomberg.com, 15. www.japantimes.co.jp, 16. www.marketwatch.com, 17. seekingalpha.com, 18. www.tradingview.com

Tags:

Mateusz Kaczmarek Latest posts

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

View all

Prestige Consumer Healthcare (PBH) Beats Q2 Earnings; Near-Term Outlook Cautious
November 6, 2025, 10:44 AM EST. Prestige Consumer Healthcare (PBH) posted Q2 earnings of $1.07 per share, ahead of the Zacks Consensus of $0.97 and marking a +10.3% surprise. Revenue came in at $274.11 million, beating the consensus by 6.87% versus year-ago revenue of $283.79 million. Over the last four quarters, PBH has beaten EPS estimates three times. The stock has slid about 23.4% year to date, underperforming the S&P 500 (+15.6%). The firm carries a Zacks Rank #4 (Sell), signaling near-term underperformance unless management provides a positive earnings outlook on the call. For the coming quarter, current estimates are $1.23 on $294.9 million in revenue; FY guidance sits at $4.51 on $1.1 billion in revenue.
Arhaus, Inc. (ARHS) Beats Q3 EPS and Revenue; Zacks Rank #2 Buy Ahead of Outlook
November 6, 2025, 10:42 AM EST. Arhaus, Inc. (ARHS) reported Q3 earnings of $0.09 per share, beating the Zacks Consensus by $0.01 and posting a +12.5% surprise from a year ago. Revenue was $344.57 million, topping estimates by about 1%. The company has exceeded EPS estimates in three of the last four quarters and has beat revenue estimates in two of the last four. Year-to-date, ARHS has risen about 3.8%, underperforming the S&P 500's gain of ~15.6%. Ahead of the call, the Zacks Rank remains #2 Buy. For the coming quarter, consensus is $0.10 per share on $348.02 million in revenue, and full-year guidance sits at $0.45 on $1.36 billion in revenue. Management commentary will shape the near-term outlook.
Epam (EPAM) Q3 Earnings Beat; Revenue Rises, But Stock Faces Mixed Outlook
November 6, 2025, 10:40 AM EST. Epam (EPAM) reported Q3 earnings of $3.08 per share, beating the Zacks Consensus Estimate of $3.02 and delivering a +1.99% surprise. Revenue reached $1.39 billion, ahead of the consensus by 1.44% versus $1.17 billion a year ago. The company has topped estimates in all four of the past four quarters. Despite the beat, shares are down about 31.2% year-to-date as the broader market climbs. Outlook signs show a current-quarter consensus of $2.90 on $1.38 billion in revenue and a full-year view of $11.11 on $5.41 billion. Market focus will shift to management commentary for earnings trajectory and any revisions to the IT Services outlook and estimates.
Cars.com Q3 Results: Revenue In Line, EBITDA Beat, Margin Expansion
November 6, 2025, 10:38 AM EST. Cars.com (NYSE:CARS) reported a Q3 that largely met expectations on revenue and adjusted earnings, while delivering a clear EBITDA beat and margin expansion. Revenue was $181.6 million, essentially in line with consensus of $181.4 million. Adjusted EPS came in at $0.48 vs $0.49 expected. Adjusted EBITDA totaled $54.63 million, ahead of the $53.51 million estimate, with a 30.1% EBITDA margin and Operating Margin of 9.3% (up from 6.4% a year ago). Free Cash Flow Margin jumped to 29% from 10.2%. Dealer Customers rose to 19,526, up 271 YoY. The company's current Market Capitalization is about $639.6 million. Looking ahead, analysts see about 2.4% revenue growth over the next 12 months, with modest long-term growth versus peers.
Thermon THR Q3 2025 Beats Estimates; Raises Revenue and EPS Guidance
November 6, 2025, 10:36 AM EST. Thermon (NYSE:THR) delivered a strong Q3 CY2025, topping estimates with revenue of $131.7 million, up 14.9% YoY. The company's non-GAAP EPS of $0.55 beat consensus by 51.7%, and Adjusted EBITDA reached $30.61 million, well above expectations. Management lifted the full-year revenue guidance to a midpoint of $516.5 million and increased the midpoint Adjusted EPS guidance to $2.08, signaling improved profitability and cash generation. The quarter's operating margin was 16.4%, while free cash flow margin stood at 3.3%. With a market cap near $972 million, Thermon remains a proxy for demand in engineered industrial process heating.